Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
1 min read
Photo: Inhaler. Photo credit: NIAID via Flickr, CC BY 2.0. Article ource: Oxford University. Technology.org – April 22, 2021.
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK’s PRINCIPLE trial in 1,779 participants.
Early treatment with inhaled budesonide shortens recovery time by a median of three days in patients with COVID-19 who are at higher risk of more severe illness and are treated in the community, finds Oxford University’s Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial. […]
